The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.

bb1 by the numbers
More From The Market Online
Wall Street

Aussie XTX slammed as fresh tech worries spurt on Wall Street. OpenAI’s IPO will be next big indicator

In case you haven’t noticed what with gold and silver going crazy, the Australian XTX technology index had an extremely poor day all

Carnavale Resources kicks off Kookynie BFS drilling

Carnavale Resources has begun an H1CY26 drilling program to support the bankable feasibility study (BFS) at…

Terrain Minerals set for Lightning strike; will explore Wildflower at the same time

Terrain Minerals (ASX: TMX) is preparing to test two prospects at the Smokebush Project in Western…
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

The ASX Today: We’re only halfway through this insane week; gold back over US$5K/oz; tech index beheaded

Greetings and welcome to ASX Today for Wednesday of Week 6, I’m Jon Davidson.